KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 1 filers reported holding KALA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,727,751 | $4,527,000 | 3.67% |
| RA Capital Management | 10,874,613 | $28,491,000 | 0.40% |
| ACT CAPITAL MANAGEMENT, LLC | 190,000 | $498,000 | 0.26% |
| Samsara BioCapital, LLC | 601,162 | $1,575,000 | 0.25% |
| Orbimed Advisors | 3,438,998 | $9,010,000 | 0.10% |
| Towercrest Capital Management | 122,500 | $321,000 | 0.06% |
| Knights of Columbus Asset Advisors LLC | 236,757 | $620,000 | 0.06% |
| Matisse Capital | 56,100 | $147,000 | 0.05% |
| Taylor Wealth Management Partners | 43,990 | $115,000 | 0.04% |
| SYMONS CAPITAL MANAGEMENT INC | 14,346 | $37,000 | 0.02% |